Latvia vs Malta: Share of e coli bloodstream infections due to antimicrobial resistant
Latvia
16.17
in 2022
Malta
13.35
in 2022
Latvia rank
34th
Malta rank
36th
Share of e coli bloodstream infections due to antimicrobial resistant over time
- Latvia
- Malta
How they compare
Latvia currently reports 16.17 against 13.35 in Malta, a difference of 2.82.
That makes Latvia's figure about 1.2 times Malta's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Latvia ahead.
Latvia ranks 34th and Malta ranks 36th of 46 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 18.83 | 16.81 | 2.03 | Latvia |
| 2020s | 22.8 | 12.77 | 10.04 | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e coli bloodstream infections due to antimicrobial resistant, Latvia or Malta?
- Latvia, at 16.17 against 13.35 in Malta as of 2022.
- What is the difference in share of e coli bloodstream infections due to antimicrobial resistant between Latvia and Malta?
- 2.82, with Latvia ahead.
- How many years of comparable data are there for Latvia and Malta?
- 6 years are reported by both, from 2017 to 2022.
- How do Latvia and Malta rank globally for share of e coli bloodstream infections due to antimicrobial resistant?
- Latvia ranks 34th and Malta ranks 36th of 46 countries.
- Where does this data come from?
- Our World in Data, published as Share of e coli bloodstream infections due to antimicrobial resistant bacteria. Statizoid refreshes it automatically from the source and publishes the full history for both places.